Evidence map›Paper›PMID 42510516›Full record

ArticleAntioxidants (Basel, Switzerland)2026

Chuyu Song, Cui Deng, Tengyue Zhang, Wei Yao, Dapeng Li, Xiangming Wang

Abstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Chuyu SongDepartment of Neurobiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Cui DengDepartment of Neurobiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Tengyue ZhangDepartment of Cell Biology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Wei YaoDepartment of Cell Biology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.
Dapeng LiDepartment of Neurobiology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.ORCID 0000-0003-0463-3828
Xiangming WangDepartment of Cell Biology, School of Basic Medical Sciences, Laboratory for Clinical Medicine, Capital Medical University, Beijing 100069, China.

Funding

National Natural Science Foundation of China 32571125
6 · The paper itself

Abstract

Alzheimer's disease (AD) lacks effective disease-modifying therapeutics. Probiotics, promising neuroprotective candidates, exert benefits mainly by modulating gut-brain-axis (GBA) signaling. This study explored the anti-AD effects and mechanisms of

Indexed as

Alzheimer’s diseaseantioxidant defenseR. pseudopalustris

Identifiers

PMID42510516
PMCPMC13403779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.